CN103041119B - One treats cardiopathic Chinese medicine - Google Patents
One treats cardiopathic Chinese medicine Download PDFInfo
- Publication number
- CN103041119B CN103041119B CN201310040841.0A CN201310040841A CN103041119B CN 103041119 B CN103041119 B CN 103041119B CN 201310040841 A CN201310040841 A CN 201310040841A CN 103041119 B CN103041119 B CN 103041119B
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- medicine
- blood
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses one and treat cardiopathic Chinese medicine, this Chinese medicine is made up of following weight proportion raw material: the Radix Astragali 20-30g, Radix Polygalae 8-10g, Radix Salviae Miltiorrhizae 10-20g, Lignum Dalbergiae Odoriferae 10-15g, Fructus Trichosanthis 20-25g, Radix Codonopsis 15-20g, Caulis Spatholobi 15-20g, Rhizoma Corydalis 15-20g, Bulbus Allii Macrostemonis 15-20g, Rhizoma Chuanxiong 15-20g.Medicine of the present invention has blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, effect of dredge the meridian passage, be used for the treatment of the thoracic obstruction of blood stasis resistance caused by numbness, disease sees ambition pain, cardiopalmus, dizziness and tinnitus, insomnia, general weakness, with the passing of time do not heal, the venation that tired aggravation and healthy energy virtual loss cause is become silted up and is hindered, and arteries and veins flesh loses supports, purplish tongue, have ecchymosis, tongue the lung-pulse is slow waits disease, evident in efficacy.Courses of pharmaceuticals of the present invention is short, instant effect, toxic and side effects are little and more after not easily recur.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to one and treat cardiopathic Chinese medicine.
Background technology
Current heart disease is the principal disease threatening human health, it is the number one killer of many countries and regions crowds in the world today, cardiovascular diseases also rises year by year at the sickness rate of China, shows according to investigations, and the existing cardiac of China has nearly 100,000,000 people, the cause of heart disease is complicated, disease indicia is varied, as arteriosclerosis, and apoplexy, cerebral thrombosiss etc., heart disease has become one of disease that in the many diseases of China, fatality rate is the highest.The cardiopathic medicine of current treatment is more, and Chinese patent medicine or natural extracts are with its better tolerance, the features such as side effect is little have obvious advantage at control cardiac disease, now more by the herbal species of wide clinical application, mainly contain components in danshen, Semen Ginkgo class, flavonoid, Moschus class, the preparations such as Pueraria DC, but the application of said medicine is with blood fat reducing, cholesterol reducing, blood vessel dilating, it is main for improving cardiac function, there is the course for the treatment of long, cure slow, after drug withdrawal, the state of an illness can recur, cure the symptoms, not the disease, the problems such as medical expense is high, a lot of misery is brought to patient.
Summary of the invention
The object of this invention is to provide one and treat cardiopathic Chinese medicine, apply that courses of pharmaceuticals of the present invention is short, instant effect, toxic and side effects are little and more after not easily recur.
For achieving the above object, technical scheme of the present invention is: one treats cardiopathic Chinese medicine, medicine of the present invention is got, the Radix Astragali: coronary artery dilator and peripheral vessels, reduce blood pressure, blood fat reducing, Radix Polygalae: calming soporific, eliminate the phlegm, antitussive, blood pressure lowering, haemolysis, Radix Salviae Miltiorrhizae: coronary artery dilator, increase blood vessels flow, improve myocardial ischemia, antithrombotic, Rhizoma Chuanxiong: coronary artery dilator, reduce myocardial oxygen consumption, expansion of cerebral vascular, reduce vascular resistance, improve microcirculation, said medicine is principal agent, Lignum Dalbergiae Odoriferae: regulating QI to relieve pain, hemostasis, eliminate the phlegm, Fructus Trichosanthis: moistening the lung and resolving phlegm, relieving stuffiness of the chest by dispersing aggregation of pathogens, Radix Codonopsis: stasis-dispelling and pain-killing, promoting blood flow to regulate menstruation, to nourish heart relieving restlessness, strengthen immunologic function, excited maincenter, raise blood sugar, raise erythrocyte, slow down aging, Caulis Spatholobi: blood circulation promoting and enriching, increase blood flow volume, reduce vascular resistance, antiinflammatory action, Rhizoma Corydalis: regulating QI to relieve pain, Bulbus Allii Macrostemonis: the chest stuffiness relieving of regulating the flow of vital energy, activating YANG and eliminating stagnation, said medicine is accessory drugs.
Chinese medicine of the present invention is made up of following weight proportion raw material: the Radix Astragali 20-30g, Radix Polygalae 8-10g, Radix Salviae Miltiorrhizae 10-20g, Lignum Dalbergiae Odoriferae 10-15g, Fructus Trichosanthis 20-25g, Radix Codonopsis 15-20g, Caulis Spatholobi 15-20g, Rhizoma Corydalis 15-20g, Bulbus Allii Macrostemonis 15-20g, Rhizoma Chuanxiong 15-20g.
Chinese medicine preferred version of the present invention is: Radix Astragali 20g, Radix Polygalae 8g, Radix Salviae Miltiorrhizae 10g, Lignum Dalbergiae Odoriferae 10g, Fructus Trichosanthis 20g, Radix Codonopsis 15g, Caulis Spatholobi 15g, Rhizoma Corydalis 15g, Bulbus Allii Macrostemonis 15g, Rhizoma Chuanxiong 20g.
Chinese medicine powder of the present invention becomes micropowder, can be made into capsule or pellet form.
Medicine of the present invention has blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, effect of dredge the meridian passage, be used for the treatment of the thoracic obstruction of blood stasis resistance caused by numbness, disease sees ambition pain, cardiopalmus, dizziness and tinnitus, insomnia, general weakness, with the passing of time do not heal, the venation that tired aggravation and healthy energy virtual loss cause is become silted up and is hindered, and arteries and veins flesh loses supports, purplish tongue, have ecchymosis, tongue the lung-pulse is slow waits disease, evident in efficacy.
Detailed description of the invention
Below by way of clinical observation, set forth the beneficial effect of Chinese medicine of the present invention further.
One, clinical data
Accept paralytic's clinical experiment report for medical treatment.
Accept patient 150 example for medical treatment, man 80 example, female 70 example, the age is between 40-70 years old.
Two, diagnostic criteria
Healthy energy virtual loss, venation silt resistance arteries and veins flesh loses supports, and facial hemiparalysis, blood stagnancy due to deficiency of QI, the tongue the lung-pulse person of delaying, has hospital's electrocardiographic diagnosis book.
Three, Therapeutic Method
Taking each 8-10 capsules of Chinese medicine of the present invention, every capsules drug containing 0.5g, every day three times, 15 days is a course for the treatment of, mild one course for the treatment of, two courses for the treatment of of serious symptom.
Four, diagnostic criteria
Cure: symptom is eliminated completely, appetite increases, and strength increases, and muscle power increases, and equally with normal person lives.
Effective: symptom part is eliminated, and appetite increases to some extent, and strength increases to some extent, and muscle power is slightly recovered.
Invalid: symptom is without obvious change.
Five, therapeutic effect
Cure 140 examples, effective 8 examples, invalid 2 examples, total effective rate reaches 99%.
(1) cardiac's clinical experiment report is accepted altogether for medical treatment.
Accept patient 150 example for medical treatment, man 100 example, female 50 example, the age is between 20-75 years old.
(2) diagnostic criteria
Pulse condition knot is for person, and the vexed pain person in anterior pectorial region, cardiopalmus is moved, and has hospital's color ultrasound, doppler diagnostic and expert consultation.
(3) Therapeutic Method
Taking each 8-10 capsules of Chinese medicine of the present invention, every capsules drug containing 0.5g, every day three times, 15 days is a course for the treatment of, mild one course for the treatment of, two courses for the treatment of of serious symptom.
(4) diagnostic criteria
Cure: symptom is eliminated, appetite increases, and muscle power increases, and lives as normal person.
Effective: symptom part is eliminated, and appetite increases to some extent, and muscle power is slightly recovered.
Invalid: symptom is without obvious change.
Five, therapeutic effect
Cure 137 examples, effective 10 examples, invalid 3 examples, total effective rate reaches 98%.
Claims (2)
1. the cardiopathic Chinese medicine for the treatment of, it is characterized in that: this Chinese medicine is made up of following weight proportion raw material: the Radix Astragali 20-30g, Radix Polygalae 8-10g, Radix Salviae Miltiorrhizae 10-20g, Lignum Dalbergiae Odoriferae 10-15g, Fructus Trichosanthis 20-25g, Radix Codonopsis 15-20g, Caulis Spatholobi 15-20g, Rhizoma Corydalis 15-20g, Bulbus Allii Macrostemonis 15-20g, Rhizoma Chuanxiong 15-20g.
2. one according to claim 1 treats cardiopathic Chinese medicine, it is characterized in that: this Chinese medicine preferred version is: Radix Astragali 20g, Radix Polygalae 8g, Radix Salviae Miltiorrhizae 10g, Lignum Dalbergiae Odoriferae 10g, Fructus Trichosanthis 20g, Radix Codonopsis 15g, Caulis Spatholobi 15g, Rhizoma Corydalis 15g, Bulbus Allii Macrostemonis 15g, Rhizoma Chuanxiong 20g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310040841.0A CN103041119B (en) | 2013-02-04 | 2013-02-04 | One treats cardiopathic Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310040841.0A CN103041119B (en) | 2013-02-04 | 2013-02-04 | One treats cardiopathic Chinese medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103041119A CN103041119A (en) | 2013-04-17 |
| CN103041119B true CN103041119B (en) | 2015-11-18 |
Family
ID=48054130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310040841.0A Active CN103041119B (en) | 2013-02-04 | 2013-02-04 | One treats cardiopathic Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103041119B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104161960A (en) * | 2014-09-02 | 2014-11-26 | 济南超舜中药科技有限公司 | Vinegar drink for treating pulmonary heart disease and preparation method thereof |
| CN107412591A (en) * | 2017-06-15 | 2017-12-01 | 合肥川迪医药技术有限公司 | One kind treats anginal medicine and preparation method thereof |
| CN108785504A (en) * | 2018-08-28 | 2018-11-13 | 刘彩芳 | Treat cardiopathic Chinese medicine |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1509732A (en) * | 2002-12-20 | 2004-07-07 | 于忠学 | Chinese medicine for treating coronary disease |
| CN1931242A (en) * | 2005-10-08 | 2007-03-21 | 周小明 | Chinese medicine composition for treating cardio palmus and its prepn process |
| CN101011519A (en) * | 2006-10-05 | 2007-08-08 | 刘学友 | Chinese medicine for treating cardiovascular and cerebrovascular disease |
| CN102552811A (en) * | 2012-01-27 | 2012-07-11 | 王政乾 | Oral Chinese medicine composition for treating apoplexy |
-
2013
- 2013-02-04 CN CN201310040841.0A patent/CN103041119B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1509732A (en) * | 2002-12-20 | 2004-07-07 | 于忠学 | Chinese medicine for treating coronary disease |
| CN1931242A (en) * | 2005-10-08 | 2007-03-21 | 周小明 | Chinese medicine composition for treating cardio palmus and its prepn process |
| CN101011519A (en) * | 2006-10-05 | 2007-08-08 | 刘学友 | Chinese medicine for treating cardiovascular and cerebrovascular disease |
| CN102552811A (en) * | 2012-01-27 | 2012-07-11 | 王政乾 | Oral Chinese medicine composition for treating apoplexy |
Non-Patent Citations (1)
| Title |
|---|
| 郝近大."复脉定胶囊".《中华人民共和国药典辅助说明.2010年版一部.中成药》.中国中医药出版社,2012,(第1版), * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103041119A (en) | 2013-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101690764B (en) | Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof | |
| CN103202879B (en) | Traditional Chinese medicine composition for treating chronic cardiac failure and preparation method thereof | |
| CN102772704A (en) | Medicament for treating geriatric disease | |
| CN101869690A (en) | Method for preparing traditional Chinese medicine for treating coronary artery disease with deficiency of both qi and yin | |
| CN103041119B (en) | One treats cardiopathic Chinese medicine | |
| CN104083438A (en) | Balsam pear-containing traditional Chinese medicinal preparation for alleviating hypertension, and preparation method thereof | |
| CN103893670A (en) | Traditional Chinese medicine pill used for treating cardia-cerebrovascular diseases | |
| CN103463467B (en) | A kind of seedling prescription wine with nourishing kidney yin | |
| CN102614462B (en) | Traditional Chinese medicine composition for curing coronary disease and preparation method thereof | |
| CN104587186A (en) | Traditional Chinese medicinal composition for treating qi and blood deficiency | |
| CN105796789A (en) | Traditional Chinese medicine preparation for treating coronary heart disease | |
| CN103285328B (en) | Traditional Chinese medicine composition capsule for treating coronary heart diseases and preparation method thereof | |
| CN103223137B (en) | Traditional Chinese medicinal preparation for reducing blood sugar | |
| CN102579633B (en) | Traditional Chinese medicine composition for curing vital energy deficiency type postpartum lochiorrhea and preparation method thereof | |
| CN102266481B (en) | Chinese medicinal preparation for treating chronic cerebral circulation insufficiency | |
| CN104224962A (en) | Traditional Chinese medicine composition for treating interstitial cystitis | |
| CN104306931A (en) | Traditional Chinese medicine formula for restoring yang and rescuing patients from collapse and preparation method of traditional Chinese medicine formula | |
| CN103330911B (en) | Chinese medicine powder for treating coronary heart disease and preparation method thereof | |
| CN103495108A (en) | Medicine for treating chronic hypotension and preparation method for medicine | |
| CN103285327B (en) | Traditional Chinese medicine composition tablet for treating coronary heart diseases and preparation method thereof | |
| CN103055159B (en) | Medicine for treating hypertension | |
| CN107260978A (en) | A kind of Chinese medicine composition and its production and use | |
| CN102961540A (en) | Medicine for treating coronary heart disease and preparation method for same | |
| CN107260890A (en) | A kind of compound quick-acting is enriched blood blood-forming agent and application | |
| CN102784376B (en) | Preparation method of traditional Chinese medicine for treating anorexia type acute glomerulonephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |